Related Experiment Video
Updated: Sep 1, 2025
08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.1K
The future of oncology policy
Jennifer L Gill1, Mackenzie J Mills1, George A Wharton2
1LSE Health - Medical Technology Research Group and Department of Health Policy, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK.
Journal of Cancer Policy
|August 11, 2022
Summary
Effective oncology healthcare policy is crucial for continued progress in cancer survival. Innovative approaches and strategic funding are needed to address challenges posed by new cancer treatments and ensure future advancements.
Area of Science:
- Oncology
- Health Policy
- Healthcare Delivery
Background:
- Cancer survival rates have improved, necessitating future-focused healthcare policies.
- Recent innovations like telehealth and real-world evidence demonstrate the potential of collaborative efforts.
- The European Beating Cancer Plan (2021-2025) promotes a comprehensive, whole-government strategy.
Purpose of the Study:
- To identify key policy considerations for oncology healthcare delivery and funding in the 21st century.
- To address the gap between the pace of oncological innovation and current policy frameworks.
- To ensure continued research and development of innovative cancer treatments.
Main Methods:
- Analysis of recent healthcare successes (e.g., COVID vaccine response, telehealth).
- Review of the European Beating Cancer Plan's strategic approach.
- Identification of policy challenges related to novel cancer therapies.
Main Results:
- Concerns exist that oncology policy lags behind rapid innovation.
- Need for consensus on pricing and reimbursement for combination therapies, cell and gene therapies, and personalized medicine.
- Importance of adequately rewarding pharmaceutical innovation to sustain R&D.
Conclusions:
- Future oncology policy must adapt to technological advancements and innovative treatment modalities.
- Developing effective payment models and pricing strategies is essential for personalized medicine.
- Sustained investment in research and development is critical for future oncology products.
Keywords:
Europe’s Beating cancer planIndication based pricing, Combination pricingOncologyPersonalised oncologyPolicyMore Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:30Cancer Vaccines
499
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
499
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:21Cancer Survival Analysis
433
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
433
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:27Tumor Immunotherapy
646
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
646